Labshake search

Citations for Selleck Chemicals :

1 - 3 of 3 citations for "S1120" since 2020

Citations are collected from bioRxiv only, the total number of publications could be much larger.

Cell line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations

Jorge Gómez Tejeda Zañudo, et al., bioRxiv - Cancer Biology 2020

Quote: ... everolimus (Selleck Chemicals # S1120), navitoclax (Selleck Chemicals # S1001) ...

Product cited:

Everolimus

Everolimus is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay....

Cat# S1120, SKU# S1120-10mM/1mL, 10mM/1mL, $87.00 Ask
Lysosomal Degradation Pathways Target Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms

Amanpreet Kaur, et al., bioRxiv - Cancer Biology 2023

Quote: ... Everolimus (S1120) and Bortezomib (S1013) were purchased from Selleck Chemicals. Human Methylcellulose enriched media (HSC005 ...

Product cited:

Everolimus

Everolimus is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay....

Cat# S1120, SKU# S1120-10mM/1mL, 10mM/1mL, $87.00 Ask
Regulation of fatty acid delivery to metastases by tumor endothelium

Deanna N. Edwards, et al., bioRxiv - Cancer Biology 2024

Quote: ... Vehicle (20% DMSO in PBS) or 0.01 mg/kg RAD001 (Selleck Chemical, #S1120) was administered daily in 100 μL ...

Product cited:

Everolimus

Everolimus is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay....

Cat# S1120, SKU# S1120-10mM/1mL, 10mM/1mL, $87.00 Ask

Feedback